Abstract-p53-dependent vascular smooth muscle cell senescence is a key pathological process of abdominal aortic aneurysm (AAA). Caloric restriction (CR) is a nonpharmacological intervention that prevents AAA formation. However, whether p53 is indispensable to the protective role of CR remains unknown. In this study, we investigated the necessity of p53 in the beneficial role of CR in AAA formation and the underlying mechanisms. We subjected p53 +/+ and p53 −/− mice to 12 weeks of CR and then examined the incidence of Ang II (angiotensin II)-induced AAA formation. We found that both CR and p53 knockout reduced Ang II-induced AAA formation; however, CR markedly increased the incidence of AAA formation and exacerbated aortic elastin degradation in p53 −/− mice, accompanied by increased vascular senescence, reactive oxygen species generation, and reduced energy production. Analysis of mitochondrial respiratory activity revealed that dysfunctional complex IV accounts for the abnormal mitochondrial respiration in p53 −/− vascular smooth muscle cells treated by CR serum. Mechanistically, ablation of p53 almost totally blocked the protective role of CR by inhibiting SCO2 (cytochrome C oxidase assembly protein 2)-dependent mitochondrial complex IV activity. Overexpression of SCO2 restored the beneficial effect of CR on antagonizing Ang II-induced expression of AAArelated molecules and reactive oxygen species generation in p53 −/− vascular smooth muscle cells. Together, our findings demonstrate that the existence of p53 in vascular smooth muscle cells is critical to the protective role of CR in Ang IIinduced AAA formation by maintaining an appropriate mitochondrial function. (Hypertension. 2019;73:547-560.
A bdominal aortic aneurysm (AAA), characterized by a dilated abdominal aorta exceeding the normal diameter by >50%, 1 is the most common form of aortic aneurysm with a high mortality after rupture. 2 AAA treatment mainly consists of surgery because no medical therapy is currently available for cure AAA. 3, 4 Advancing age is a critical uncontrollable risk factor of the pathogenesis and development of AAA, as evidenced by the phenomenon that AAAs usually exist in men aged >65 years and the incidence steeply increases with aging. 5 Therefore, management of lifestyle and dietary intervention for counteracting the aging process and age-related pathological changes is crucial for prevention of AAA. As a convenient dietary intervention, calorie restriction (CR) has been reported to exert beneficial effects on slowing the aging process in a wide variety of organisms ranging from yeast to primates without causing malnutrition. 6 Besides reducing mortality, 7 CR also reduces risk factors of age-related cardiovascular diseases in humans. [8] [9] [10] A previous study indicates that CR prevents AAA formation by activating vascular smooth muscle cell (VSMC)-derived SIRT1 (Sirtuin 1)-a critical antisenescent molecule.
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Cellular senescence-a permanent proliferative arrest status in response to various stressors-is involved in normal aging and development of age-related diseases, such as type-2 diabetes mellitus, cardiovascular diseases, and cancer. 12 In vasculature, senescent VSMCs actively produce proinflammatory and matrix-degrading molecules, what is known as the senescence-associated secretory phenotype, thus facilitate AAA formation. Our previous study also observed that senescent VSMCs accumulate in AAA, accompanied by overexpression of p53-the critical marker protein of cell senescence. 13 p53 acts as a critical transcription factor affecting cell-cycle control, DNA repair, apoptosis, and senescence. p53 regulates a series of target genes affecting physiological and metabolic pathways involved in aging and senescence. 14 Apart from being a well-known tumor suppressor gene, p53 also participates in the development of vascular diseases, such as atherosclerosis 15 and AAA. 16 However, whether CR prevents AAA formation by repressing p53-mediated VSMC senescence remains unknown.
Mitochondrial dysfunction is a critical determinant of aging phenotypes. Dysfunctional mitochondria not only accumulate in aged tissues 17 but also induce cellular senescence in vitro 18 and in vivo. 19 In addition, mitochondrial dysfunction-associated senescence also depends on p53 activation. 20 Although active p53 represses expression of PGC-1α (peroxisome proliferator-activated receptor-γ, coactivator 1α), a critical transcription factor contributing to mitochondrial biogenesis thereby reduces oxygen consumption and increases reactive oxygen species (ROS) levels 21 ; basal p53 activity is necessary for normal mitochondrial function because p53 promotes the expression of synthesis of SCO2 (cytochrome C oxidase 2)-a component of the complex IV of the electron transport chain. 22 However, whether p53 plays a positive or negative role in mitochondrial dysfunction in vasculature and the beneficial effect of CR on AAA formation has not been investigated yet.
In the present study, we investigated the role of p53 in the beneficial effect of CR on AAA formation by establishing an Ang II (angiotensin II)-induced AAA model on p53 knockout (p53 −/− ) mice. We observed that CR reversely promoted the AAA formation in Ang II-infused p53 −/− mice, accompanied by an exaggerated mitochondrial dysfunction in VSMCs because of inability of the complex IV. These results revealed that the preventive effect of CR on AAA formation is relied on p53-mediated mitochondrial function.
Methods
The data that support the findings of this study are available from the corresponding author on reasonable request. The detailed experimental protocols are available in the online-only Data Supplement.
Animal Experiments
The p53 knockout (p53 −/− ) mice 23 in C57BL/6 background was a kind gift from the laboratory of Prof De-Pei Liu in the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, and Peking Union Medical College. All mice were housed in cages at a controlled temperature (22±1°C) and relative humidity (55±5%) in a 12-hour light/dark cycle. Eight-week-old male p53 +/+ or p53 −/− mice were housed individually and randomly allocated into 4 groups. Ad libitum (AL)-saline mice and AL-Ang II mice were fed AL with AL food for 16 weeks, whereas CR-saline mice and CR-Ang II mice were fed a 10%-restricted diet for the first week and a 25%-restricted diet for the remaining experimental period of the CR diet. The AL and CR food were produced according to the composition of AIN-93M, 24 and the feeding amount of CR group was calculated based on the food intake of AL group. During the last 4 weeks, some mice in each group were infused with Ang II (Sigma-Aldrich, Cat No. A9525) using Alzet osmotic pumps (model 2004; DURECT Corp) at a dosage of 1.44 mg/ kg per day to establish the AAA model, 25 whereas others were infused with saline as control. For in vivo treatment of pifithrin-α, wild-type mice were received intraperitoneal injections of pifithrin-α (SigmaAldrich, Cat No. 506132) at a dose of 2.2 mg/kg twice on days 1 and 15 during Ang II intervention to inhibit the activity of p53 as described previously. 26, 27 In the last week of the experiment, the mice underwent indirect calorimetry, intraperitoneal glucose tolerance test, and blood pressure measurement. After sacrifice, the whole aorta, heart, epididymal white adipose tissue, liver, and 2 kidneys were carefully removed, photographed, and weighed. The maximum width of the abdominal aorta was analyzed using Image Pro Plus software (Media Cybernetics). AAA formation was defined as the increase in the external width of the suprarenal aorta by ≥50% compared with that in saline-infused mice as described previously. 25 The aortas were stained or homogenate to determine SA-β-gal (senescence-associated β-galactosidase) activity as reported previously. 13 Some abdominal aortas were removed and stored at −70°C for Western blot or real-time polymerase chain reaction analysis; the others were embedded and sliced for elastin van Gieson staining. The primers used in real-time polymerase chain reaction analysis are listed in Table S1 in the online-only Data Supplement. All experimental procedures were performed in accordance with protocols approved by the Institutional Animal Care and Research Advisory Committee at Daping Hospital, Third Military Medical University.
Statistical Analyses
Quantitative results are expressed as the means±SD. The normality and the homogeneity of variance of the data were tested. The differences among ≥3 groups were analyzed using 1-way ANOVA followed by the Bonferroni adjustment for multiple comparisons, and a Kruskal-Wallis test plus a post hoc analysis (Dunn multiple comparison test) was used for variables not passing a normality or equal variance test. Two-way ANOVA was used for body weight (BW) data and intraperitoneal glucose tolerance test data that were repeatedly measured. Fisher exact test was applied to the comparisons of AAA incidence, and the log-rank (Mantel-Cox) test was used for survival analysis. Graphs were created using Prism 6.0 (GraphPad Software), and statistical analysis was performed with GraphPad Prism. A P <0.05 was considered to be statistically significant. No statistical method was used to predetermine sample size.
Results

Knockout of p53 Does Not Affect the Beneficial Effects of CR on Metabolism
To determine whether p53 is critical to the inhibitory effect of CR on AAA formation, p53 wild-type (p53 +/+ ) mice and their knockout littermates (p53 −/− ) were calorie restricted or fed AL for 12 weeks as described. 28 Then, Ang II infusion was performed on the experimental group for 4 weeks to induce AAA formation ( Figure 1A ). The food intake of AL mice, based on which was the feeding amount of corresponding CR group calculated, gradually decreased with time. p53 −/− mice consumed equal amount of food compared with p53 +/+ mice ( Figure 1B ). During the experimental process, the BW of AL mice was stably increased, whereas that of CR mice significantly decreased in the first 4 weeks and slowly recovered thereafter. Neither knockout of p53 nor Ang II infusion obviously affected the BW changes in AL or CR group ( Figure 1C) .
Because no mice died of AAA rupture or tumor in Ang II-infused groups in the present study, the 4 saline-infused control groups were chosen to analyze the difference in survival rate. As reported previously, 23 p53 knockout mice were prone to develop spontaneous tumors, and 75% of them (6 of 8) died at the end of the experiment, whereas the death rate of p53 +/+ mice was only 10% (2 of 20; P<0.0001). CR remarkably lowered the death rate of p53 −/− mice to 36.36% (8 of 22; P=0.0385; AL versus CR) without affecting that of p53 +/+ mice ( Figure 1D ). At the end of experiment, the glucose tolerance was analyzed in all 8 groups of mice using an intraperitoneal glucose tolerance test. After glucose injection (2 g/ kg BW), the blood glucose levels of AL mice increased much higher than CR mice in the 3 time points within 60 minutes, and either Ang II treatment or p53 knockout failed to affect the promotional effect of CR on glucose tolerance ( Figure 1E ). In addition, CR remarkably lowered the epididymal white adipose tissue-to-BW ratio without influencing the liver weightto-BW ratio, and these 2 indexes were comparable in the 4 CR groups ( Figure 1F ). These results indicate that p53 knockout could not affect the beneficial role of CR in improving glucose and lipid metabolism, and the antitumor effect of CR was also independent of p53. Ang II-induced AAAs. Additionally, CR also displayed a potent protective role and reduced the AAA incidence of Ang II-infused p53 +/+ mice to 15.38% (4 of 26). But to our surprise, p53 knockout almost totally erased the antianeurysmal effect of CR on Ang II-induced AAAs, as AAAs appeared in 60.0% (12 of 20) CR-Ang II p53 −/− mice ( Figure 2A and 2B). Accordingly, Ang II infusion markedly increased maximal abdominal aortic diameter and the aortic weight-to-BW ratio in AL-p53 +/+ mice, and these effects were significantly alleviated in p53 −/− mice ( Figure 2C ). Moreover, the inhibitory effects of CR on Ang II-induced increase in these indexes were also blocked in the absence of p53 ( Figure 2C ). Changes in the heart weight-to-BW ratio displayed a similar trend as aorta ( Figure 2C ). Ang II infusion, CR, or p53 knockout failed to affect the kidney weight-to-BW ratio ( Figure S1A and S1B). Ang II infusion also increased systolic blood pressure in AL-p53 +/+ mice, whereas either CR or p53 knockout did not affect Ang II-induced elevation of systolic blood pressure (Figure S1C through S1F).
CR Exacerbates
Next, the results of elastin van Gieson staining demonstrated that the elastic lamina in the aortas of saline-infused mice was regularly arranged and could be seriously disrupted and degraded by Ang II infusion ( Figure 2D ). The aortic elastin was more preserved, and the elastin degradation score was obviously lower in AL-Ang II p53 −/− mice or CR-Ang II p53
mice compared with AL-Ang II p53 +/+ mice, indicating that both knockout of p53 and CR protected against Ang II-induced elastin degradation (Figure 2D and 2E) . However, CR resulted in an exaggerated elastin fragmentation and breakage in Ang II-infused p53 −/− mice ( Figure 2D and 2E). Consistently, the inhibitory effects of CR on both protein and mRNA expression of some key molecules participating in ECM (extracellular matrix) degradation or inflammation of artery wall, including MMP2 (matrix metalloproteinase 2), MCP1/CCL2 (monocyte chemotactic protein-1/C-C motif chemokine ligand 2), and IL-6 (interleukin-6), were also reversed by p53 knockout under the treatment of Ang II ( Figure 2F ; Figure S2A ). To further confirm the blocking effect of p53 knockout on CR, primary VSMCs isolated from the suprarenal region of abdominal aortas of p53 +/+ and p53 −/− mice were incubated with the serum from AL or CR mice and then treated with Ang II. In accordance to the in vivo results, the effect of CR serum on protecting Ang II-induced Mmp2 or Ccl2 overexpression was also hampered in p53 −/− VSMCs ( Figure S2B ). These results indicate that the existence of p53 is critical to the beneficial effects of CR on Ang II-induced AAA formation.
Abnormal Energy Metabolism Contributes to the Aggravated AAA Formation in CR-p53 Knockout Mice
Because VSMC senescence is a predominant factor facilitating AAA formation, 13 SA-β-gal staining was performed in mice aortas. Few obvious SA-β-gal-positive areas were detected in the aortas of the 4 saline-infused groups, and Ang II infusion led to the enlargement of SA-β-gal-positive regions in the aortas of AL-p53 +/+ mice, which was significantly reduced by knockout of p53 or CR ( Figure 3A) . However, CR resulted in an enormous accumulation of senescent VSMCs at the AAA site on the aortas of Ang II-infused p53 −/− mice ( Figure 3A) . Consistently, the results of SA-β-gal activity assay in the homogenates of whole aortas also confirmed that the suppressive effect of CR on vascular senescence was indeed blocked by p53 knockout ( Figure 3B ). By detecting the expression of senescence-associated molecules in the aortas, we found that although knockout of p53 remarkably lowered Ang II-induced p21 expression, it also led to an obvious overexpression of p16 and activation of NF-κB (nuclear factor-κB) signaling pathway. Additionally, the inhibitory effects of CR on these molecules disappeared in the aortas of p53 −/− mice ( Figure S3A ). These results suggest that increased p16 expression and activated NF-κB signaling pathway contribute to the aggravated vascular senescence in the aortas of CR-Ang II p53 −/− mice. Enhanced generation of ROS plays a key role in AAA formation by increasing elastin degradation and inflammation. 29 Thus, we then assessed ROS levels in thoracic aortas proximal to the AAA site. Ang II remarkably induced an increase in total ROS levels (superoxide measured by dihydroethidium staining) in the aortas, which was significantly suppressed in AL-p53 −/− or CR-p53 +/+ mice ( Figure 3C ). However, the ROS generation in the aortas of CR-Ang II p53 −/− mice was similar to that of AL-Ang II p53 +/+ mice, indicating that the suppressive effect of CR on ROS generation was impaired ( Figure 3C ). Measuring mitochondrial ROS by MitoSOX staining also displayed a similar result ( Figure 3D ). Consistent with the in vivo results, treatment of p53 +/+ VSMCs with CR serum also suppressed the increase of dihydroethidium or MitoSOX fluorescent signal level in response to Ang II intervention, whereas this effect was totally blocked or even reversed in p53 −/− VSMCs ( Figure S3B and S3C). To determine whether the unexpected devastating effect of p53 knockout on CR mice depends on the alteration of systemic metabolism, the respiratory exchange ratio, energy expenditure, and heat production of all groups of mice were examined using indirect calorimetry. The results revealed that CR significantly decreased respiratory exchange ratio in p53 +/+ or p53 −/− mice, which was counteracted by Ang II treatment, and p53 knockout did not affect this index ( Figure 3E ). However, p53 knockout significantly reduced the levels of O 2 consumption and CO 2 production in Ang II-treated CR mice, especially in the night when mice were usually more active ( Figure S3D and S3E) . Consistently, both energy expenditure and heat production of CR-Ang II group were also remarkably lowered in the absence of p53 (Figure 3E ), indicating a serious blockage existing in the process of energy production in these mice, which might be a reason for the exacerbated ROS generation in CR-Ang II p53 −/− mice.
Inactivate Complex IV Accounts for the Abnormal Mitochondrial Respiration in CR-p53 −/− VSMCs
As mitochondria generate excessive ROS because of decreased complex activity in the oxidative respiratory chain, 30 we next investigated the effect of CR serum on mitochondrial respiratory functions in VSMCs using a protocol detecting the capacity of oxidative phosphorylation (OXPHOS) of complexes I and II, electron transfer (ETS) of complexes I, II, and IV, and proton leak (LEAK) of complex I ( Figure 4A ). Specifically, Ang II treatment obviously lowered all parameters of mitochondrial respiratory function, including CI LEAK, CI OXPHOS, CI+II OXPHOS, CI+II ETS, and CIV ETS, which were significantly recovered by CR serum (Figure 4A ), indicating that both Ang II and CR affected mitochondrial function in a wide range regardless of respective type of complex. We also observed that knockout of p53 not only protected against Ang II-reduced activity of complexes I and II in AL group but also promoted complex I LEAK and OXPHOS when treated with CR serum ( Figure 4A ). However, the beneficial effects of CR serum on antagonizing Ang II-reduced CI+II OXPHOS and ETS were totally blocked or even reversed in p53 −/− VSMCs ( Figure 4A ). Noticeably, the activity of complex IV was kept at a low level in p53 −/− VSMCs no matter what intervention method was used ( Figure 4A) , indicating that the effect of p53 knockout was mainly dependent on the reduced activity of complex IV. Consistently, the results of enzyme activities of complex I, II, or IV, detected by in vitro assay kits, also displayed a similar trend to that from the respirometry ( Figure 4B ). In addition, the ATP and ROS production in VSMCs was assayed to reflect the function of mitochondria. The ATP level significantly decreased in p53 +/+ VSMCs treated by Ang II compared with p53 −/− VSMCs, accompanied by a much higher cellular H 2 O 2 content (Figure 4C and 4D) . Also, the protective effect of CR serum on inhibiting Ang II-restricted ATP production was erased in p53 −/− VSMCs, with an even higher H 2 O 2 content than Ang II-treated p53 +/+ VSMCs ( Figure 4C  and 4D ). Because knockout of p53 promotes anaerobic respiration and glycolysis, 22 we also detected the glycolysis level. The results clearly indicated that the glycolysis level was increased in p53 −/− VSMCs and could be stimulated by Ang II treatment. Unexpectedly, p53 knockout restricted Ang II-induced elevation of glycolysis in VSMCs treated with AL serum but significantly promotes glycolysis in those with CR serum ( Figure 4E ). These results suggest that enhanced glycolysis in CR serum-treated p53 −/− VSMCs could be a consequence of blockage of mitochondrial ETS chain. Collectively, it could be deduced that impaired complex IV activity in p53 −/− VSMCs might account for the exceptional regulatory pattern of CR in these cells.
Knockout of p53 Specifically Inhibits the Promotional Effect of CR on Sco2 Expression
To further investigate the molecular mechanism, we detected the expression levels of several molecules participating in the assembly of mitochondrial OXPHOS complexes in mice aortas, including Ndufa9 (CI), Sdhb (CII), Sco1/2 (CIV), Atp5a1, Atp5b (CV), as well as the critical modulator promoting mitochondrial biogenesis, Pgc-1α. The results showed that the protein level of PGC-1α could be significantly enhanced by both CR and p53 knockout, especially under Ang II treatment ( Figure 5A ). Consistently, the mRNA expression of Pgc-1α in the aortas of CR-Ang II-infused p53 −/− mice was strikingly stimulated compared with their littermates ( Figure S4A) . Similarly, the mRNA expression levels of Ndufa9, Sdhb, Atp5a1, and Atp5b were also significantly elevated by p53 knockout in Ang II-treated CR mice ( Figure S4A ). Compared with Sco1, knockout of p53 was more likely to affect the expression of Sco2 because both protein and mRNA levels of Sco2 were obviously decreased in the aortas of p53 −/− mice ( Figure 5A and 5B). Consistently, the in vitro results performed in cultured primary VSMCs also demonstrated that p53 knockout significantly stimulated the expression of Pgc-1α, Ndufa9, Sdhb, and Atp5a1, especially when combined treatment with Ang II and CR serum, but the expression of Sco2 was specifically downregulated in p53 −/− VSMCs ( Figure  S4B ). These results suggest that reduced expression of Sco2 in p53 −/− VSMCs contributes to the abnormal effect of CR. Further, pifithrin-α-a small molecule inhibiting p53 transcriptional activity 31 -and nutlin-3-an activator of p53 32 -were used in p53 +/+ VSMCs to determine whether the reduced expression of Sco2 depends on lowered p53 transcriptional activity. At the baseline, pifithrin-α indeed suppressed the protein or mRNA expression of p21 or Sco2, which was elevated by nutlin-3, without affecting Sco1 and other AAA-related molecules (Figure 5C and 5D ; Figure  S5A and S5B). Treatment of pifithrin-α suppressed Ang IIinduced expression of AAA-related molecules but promoted their expression when treated with CR serum. In addition, pifithrin-α also blocked the promotional effect of CR serum on Sco2 expression ( Figure 5C and 5D ). In contrast, although activation of p53 by nutlin-3 also promoted Ang II-stimulated AAA-related molecules, it did not affect the beneficial effect of CR serum ( Figure 5C ; Figure S5A and S5B). Next, we also applied pifithrin-α intervention in vivo as described previously. 26, 27 Although the difference was not significant, intervention of pifithrin-α lowered the AAA incidence of Ang II-infused mice from 30% (3 of 10) to 10% (1 of 10). In addition, the inhibitory effect of CR on Ang II-induced AAA formation was also blocked by pifithrin-α (CR group: 16.67% [2 of 12] versus CR plus pifithrin-α group: 38.46% [5 of 13] ; Figure 5E and 5F). Consistently, intervention of pifithrin-α also increased the maximum abdominal aortic diameter and aorta weight in Ang II-infused CR mice compared with vehicle controls ( Figure 5F ). These results suggest that in vivo inhibition of p53 activity can achieve similar results as p53 knockout. Therefore, it could be concluded from these data that the reduced Sco2 expression and the abnormal effect of CR are relied on the insufficiency of p53 transcriptional activity.
Exogenous Overexpression of Sco2 Restores the Benefit of CR in p53 −/− VSMCs
To further determine the direct binding of p53 on the promoter of Sco2, we performed chromatin immunoprecipitation assay in p53 +/+ and p53 −/− VSMCs and observed that the binding of p53 on Sco2 promoter indeed existed in p53 +/+ VSMCs but disappeared in p53 −/− VSMCs, and no positive signal could be detected from Sco1 promoter ( Figure 6A ). In addition, the binding level of p53 on the promoter of Sco2 could be significantly increased by Ang II treatment ( Figure 6A ), indicating that p53 was critical to the transcriptional activation of Sco2 by direct binding on its promoter.
Next, to confirm whether Sco2 was critical to the abnormal effect of CR in p53 −/− VSMCs, a rescue experiment was performed using adenovirus expressing exogenous mouse Sco2 gene. Transfection of Ad-Sco2 significantly increased the mRNA and protein levels of Sco2 without affecting the expression of p53, p21, or Sco1, indicating Sco2 was a downstream target of p53 ( Figure 6B ; Figure S6 and S7). And overexpression of Sco2 did not obviously affect Ang II-stimulated high expression of AAA-related molecules and the protective role of CR serum in p53 +/+ VSMCs. However, p53 −/− VSMCs transfected with Ad-Sco2 displayed an obviously lowered expression of AAA-related molecules when treated with CR serum than AL group, whereas the abnormal regulatory pattern of CR serum still existed in the cells transfected with control Ad-GFP ( Figure 6B and 6C) . Additionally, the promotional effect of p53 knockout on the expression of Pgc-1a was also reduced by Ad-Sco2 ( Figure S7 ).
In addition, transfection of Ad-Sco2 also significantly increased the enzyme activity of complex IV without affecting complex I or II ( Figure 6D) . Moreover, the inhibitory effects of CR serum on all these 3 complexes could be Figure 6D) . Consistently, the aggravated cytosolic or mitochondrial ROS generation by CR serum in Ang II-treated p53 −/− VSMCs was also remarkably reduced by Sco2 overexpression ( Figure 6E) . Also, the beneficial effect of CR serum on Ang II-induced increase in glycolysis activity could be normalized by addition of Ad-Sco2 in p53 −/− VSMCs ( Figure 6F ). Collectively, these results indicate that the reduced Sco2 expression was the chief culprit accounting for the blockage of CR benefit in Ang II-treated p53 −/− VSMCs, which could be restored by exogenous addition of Sco2.
Discussion
In the present study, we used p53 knockout mice to determine that CR protects against AAA formation by improving p53-mediated mitochondrial function in VSMCs. We observed that CR reversely exacerbated Ang II-induced AAA formation in p53 −/− mice. Furthermore, p53 knockout blocked the effectiveness of CR in preventing AAA by reducing the expression of Sco2. Our findings suggest a critical role for p53-dependent mitochondrial normal function in mediating the protective effects of CR on AAA formation.
Increased p53-mediated VSMC apoptosis has been regarded as a main reason of medial degeneration in AAA formation. 33 Our previous study also demonstrates that increased VSMC senescence accompanied by overexpression of p53 contributes to Ang II-induced AAA formation. 13 Similarly, p53 also inhibits cell proliferation and promotes VSMC apoptosis in another common vascular disease, atherosclerosis, and adenovirus-mediated p53 overexpression induces plaque rupture and apoptosis in a atherosclerotic mice model 34 and in human saphenous vein intima and media. 35 In the present study, we also determined that p53 knockout reduced AAA formation in Ang II-infused mouse model. Moreover, similar to our results, administration of pifithrin-α blocked the promotional effect of Foxe3 deficiency on thoracic aortic aneurysm formation by inhibition of p53 activity. 36 In the present study, treatment of pifithrin-α also inhibited Ang II-induced excessive expression of AAA-related molecules in VSMCs and attenuated AAA formation in vivo. These studies all prove that p53 plays a critical role in mediating vascular senescence, and inhibition or deficiency of p53 protects against AAA formation. Meanwhile, we noticed that p53 knockout promoted an overexpression of p16-another critical effector of senescence-as described previously. 37 In addition, p53 deficiency is also an important trigger activating NF-κB signaling, which is involved in the induction of the senescence-associated secretory phenotype. 38 Consistently, we observed an increased expression of senescence-associated secretory phenotyperelated molecules, including Ccl2, IL-6, and Mmp2, in Ang II-infused CR-p53 −/− aortas and VSMCs, indicating that CR promotes VSMC senescence in the absence of p53 by stimulating other backup modulators, which might be a critical step for AAA formation.
Many solid tumors and cancer cell lines display enhanced glycolysis and impaired OXPHOS, termed as the Warburg effect, possibly because that they are more inclined to be exposed to a relative low-oxygen microenvironment. 39 Malignant cells are addicted to and are dependent on glycolysis to generate enough ATP to meet the requirement of rapid proliferation. Although p53 is frequently increased by DNA damage and oncogene activation, it is also activated by a series of cellular stresses, including hypoxia. 40 As the most common events in tumorigenesis, loss and mutation of p53 lead to decreased oxygen consumption and increased glycolysis, which promotes the development of tumor. 22 Interestingly, similar to solid tumors, AAAs also display a metabolic switch to glycolysis as an adaptive response to rapid growth. 41 And restriction of glycolysis by intraperitoneal 2-deoxyglucose administration to the experimental murine models attenuated the aneurysm development. 42 In our study, we also observed a significant increase of glycolysis in the aortas of Ang IIinfused mice, which might be suppressed by CR as discussed elsewhere. 43 By contrast, CR-p53 −/− mice displayed a significant decline of oxygen consumption and enhanced AAA formation, and CR serum-treated p53 −/− VSMCs also displayed an enhanced glycolysis in response to Ang II, suggesting that exaggerated glycolysis would participate in the promotional effect of p53 knockout on AAA formation under CR condition and the inhibitory effect of CR on glycolysis was also dependent on the existence of p53. Because p53 is a potent inhibitor of glycolysis 22 and enhanced glycolysis is a characteristic of aging, 44 p53 knockout under CR might also accelerate VSMC senescence and AAA formation via promoting the metabolic switch in aorta. On the contrary, inflammatory responses also facilitate the development of different stages of tumor, including initiation, promotion, malignant conversion, invasion, and metastasis. 45 NF-κB-the most critical proinflammatory molecule-is constitutively active in many types of cancer. 46 Similarly, activation of NF-κB also promotes AAA formation as deletion of RelA subunit in NF-κB complex blocks aortic vascular inflammation and AAAs. 47 Because p53 deficiency activates NF-κB signaling, 38 we also observed an activated NF-κB signaling pathway in vascular wall of p53 −/− mice, which might also play a role in the enhanced AAA formation in Ang II-infused CR-p53 −/− mice. CR has been reported to cause high efficient electron transport through the respiratory chain to produce enough ATP. 48 Similar to a previous report, 49 we also found an overall increased expression of mitochondrial oxidative complexes in the aortas from CR mice, suggesting that the promotion of mitochondrial biogenesis and bioenergetic efficiency contribute to the inhibitory effect of CR on AAA formation. Consistently, treatment of VSMCs with serum from CR mice displayed enhanced oxidative respiration and ETS, accompanied by a lowered ROS production. 50 In contrast, treatment of Ang II remarkably reduced OXPHOS and ETS by direct damage the biogenesis and assembly of mitochondria and oxidative respiratory chain. 51 As a direct target of p53, 22 the expression of SCO2 in blood vessel and VSMCs decreased significantly, which might result in the disruption of the assembly and dysfunction of mitochondrial complex IV in the study. Thus, although CR indeed counteracted Ang II infusion by promoting oxidative respiration and overall mitochondrial bioenergetic efficiency, the enhanced electron transport under CR condition was blocked by dysfunctional complex IV in the absence of p53. Then, the generation of ROS by mitochondria would be aggravated in the vascular wall as the electrons could not be properly transferred to produce ATP, which could explain why the beneficial effects of CR on AAA formation and related biological processes were blocked or even reversed in p53 −/− mice. Indeed, adenovirus-mediated overexpression of exogenous SCO2 significantly balanced the effects of p53 knockout, further emphasized the importance of complex IV function in the beneficial role of CR. In addition, our results also suggest that in the case of AL, p53 knockout, similar to CR, would promote the expression of mitochondrial complex members induced by PGC-1α and to some extent counteract the damage on mitochondrial complex by Ang II. Under this condition, although the expression of SCO2 could be still reduced in the absence of p53, it would be sufficient to maintain normal ETS. However, in the case of CR, CR further strengthens the expression and activity of mitochondrial complexes and enhances the efficiency of ETS, which could be blocked by knockout of p53, resulting in more ROS generation. This might explain why CR displayed the opposite effects in the presence and absence of p53 in this study.
It is worth noting that most of the mechanisms of CR in this study were obtained by interfering in vitro VSMCs with the serum from CR mice, suggesting that the protective effect of CR may depend on some active ingredients in the serum. It has been previously reported that the content of IGF-1 (insulin-like growth factor 1) in serum of CR rodents has been reduced by as much as 40%, and the addition of IGF-1 blocks the inhibitory effect of CR serum on the oxidative stress in cells. 52 In addition, IGF-1 treatment inhibits SIRT1 deacetylase activity, resulting in increased p53 acetylation, as well as p53 stabilization and activation. 53 Therefore, we deduce that the decrease of IGF-1 level in CR serum may be a possible reason for the decreased p53 expression in the present study. However, the results of in vitro experiments could not fully explain the real process in vivo, so the exact mechanism of the functional ingredients in CR serum needs to be further clarified. In addition, although we did not examine whether p53 knockout also influences the beneficial effect of CR on lifespan extension because of time limit, CR indeed lowered the mortality of p53 −/− mice and postponed their death because of spontaneous tumor formation in our study, 54 indicating that deficiency of p53 blocked the beneficial role of CR in AAA formation without affecting its other benefits. Although CR lowered the spontaneous tumorigenesis of p53 −/− mice, because all p53 −/− mice used for Ang II intervention were those without tumors, whether CR could protect the tumorigenesis of p53 −/− mice under Ang II treatment remains unknown. Unfortunately, because there is no report on the mutation or deficiency of p53 in clinical AAA samples, whether accumulation of dysfunctional p53 also participates in AAA formation in humans, especially those with low caloric intake, and its potential usage in clinical practice still warrants further investigation.
Perspectives
The present study determines that p53 acts as a critical mediator of the beneficial effect of CR on AAA formation in mice. Moreover, CR reversely exacerbates Ang II-induced AAAs in the absence of p53 because of the breakage of mitochondrial electron transport by reduction of Sco2. Our findings support the necessity of Sco2-mediated mitochondrial complex IV activity in the protective effect of CR on Ang II-induced VSMC mitochondrial dysfunction, senescence, and expression of inflammatory cytokines, suggesting that to maintain appropriate p53 expression level and mitochondrial activity is a promising measure for prevention and cure of AAA.
